United Advisor Group’s AbbVie ABBV Stock Holding History

United Advisor Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.43M	Sell	5,691 -59	-1%	-$12.7K	0.15%	160
2026 Q1	$1.25M	Buy	5,750 +53	+0.9%	+$11.8K	0.15%	160
2025 Q4	$1.3M	Buy	5,697 +272	+5%	+$62K	0.16%	151
2025 Q3	$1.26M	Buy	5,425 +2,317	+75%	+$472K	0.17%	140
2025 Q2	$577K	Buy	3,108 +190	+7%	+$35.3K	0.1%	200
2025 Q1	$611K	Sell	2,918 -1,554	-35%	-$302K	0.13%	164
2024 Q4	$795K	Buy	4,472 +90	+2%	+$16.5K	0.16%	149
2024 Q3	$865K	Buy	4,382 +2,075	+90%	+$387K	0.2%	118
2024 Q2	$396K	Buy	+2,307	New	+$382K	0.12%	166

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

United Advisor Group's ABBV Position: Q2 2026 in Review

United Advisor Group reduced its AbbVie (ABBV) stake by 1% in Q2 2026, selling an estimated $12.7K and leaving 5,691 shares worth $1.43M. The position accounts for 0.15% of the portfolio, ranked #160.

United Advisor Group first reported a position in ABBV in Q2 2024 and has held it in 9 quarters since. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

United Advisor Group held 5,691 shares of AbbVie worth $1.43M as of Q2 2026.
United Advisor Group sold 59 AbbVie shares in Q2 2026, an estimated $12.7K.
AbbVie made up 0.15% of United Advisor Group's portfolio in Q2 2026, its #160 holding.
United Advisor Group first reported a position in AbbVie in Q2 2024 and has held it in 9 quarters since.
4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on United Advisor Group's 13F filing for Q2 2026, filed 29 Jul 2026.